Ven Bio Global Strategic Fund Ii L.P. Checkmate Pharmaceuticals, Inc. (CMPI) insider trading activity

Ven Bio Global Strategic Fund Ii L.P. is > 10% Shareholder of Checkmate Pharmaceuticals, Inc.. Currently has a direct ownership of 2.16 Million shares of CMPI, which is worth approximately $22.6 Million. The most recent transaction as insider was on May 16, 2022, when has been sold 95,800 shares (Common Stock) at a price of $10.45 per share, resulting in proceeds of $1,001,110. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.16M

0% 3M change

0% 12M change

Total Value Held $22.6 Million

venBio Global Strategic Fund II L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2022	SELL Open market or private sale	$1,001,110 $10.45 p/Share	95,800 Reduced 4.25%	2,155,930 Common Stock
May 13 2022	SELL Open market or private sale	$374,632 $10.45 p/Share	35,850 Reduced 1.57%	2,251,730 Common Stock
May 12 2022	SELL Open market or private sale	$1,293,815 $10.39 p/Share	124,525 Reduced 5.16%	2,287,580 Common Stock
May 11 2022	SELL Open market or private sale	$183,726 $10.38 p/Share	17,700 Reduced 0.73%	2,412,105 Common Stock
May 10 2022	SELL Open market or private sale	$193,857 $10.38 p/Share	18,676 Reduced 0.76%	2,429,805 Common Stock
May 09 2022	SELL Open market or private sale	$182,512 $10.37 p/Share	17,600 Reduced 0.71%	2,448,481 Common Stock
May 06 2022	SELL Open market or private sale	$501,224 $10.37 p/Share	48,334 Reduced 1.92%	2,466,081 Common Stock
May 05 2022	SELL Open market or private sale	$215,105 $10.37 p/Share	20,743 Reduced 0.82%	2,514,415 Common Stock
May 04 2022	SELL Open market or private sale	$388,875 $10.37 p/Share	37,500 Reduced 1.46%	2,535,158 Common Stock
May 03 2022	SELL Open market or private sale	$824,156 $10.37 p/Share	79,475 Reduced 3.0%	2,572,658 Common Stock
May 02 2022	SELL Open market or private sale	$1,595,406 $10.38 p/Share	153,700 Reduced 5.48%	2,652,133 Common Stock
Apr 29 2022	SELL Open market or private sale	$718,607 $10.38 p/Share	69,230 Reduced 2.41%	2,805,833 Common Stock
Apr 28 2022	SELL Open market or private sale	$761,892 $10.38 p/Share	73,400 Reduced 2.49%	2,875,063 Common Stock
Apr 27 2022	SELL Open market or private sale	$491,970 $10.38 p/Share	47,396 Reduced 1.58%	2,948,463 Common Stock
Apr 26 2022	SELL Open market or private sale	$671,410 $10.38 p/Share	64,683 Reduced 2.11%	2,995,859 Common Stock
Apr 25 2022	SELL Open market or private sale	$287,471 $10.39 p/Share	27,668 Reduced 0.9%	3,060,542 Common Stock
Apr 22 2022	SELL Open market or private sale	$388,898 $10.39 p/Share	37,430 Reduced 1.2%	3,088,210 Common Stock
Apr 21 2022	SELL Open market or private sale	$645,636 $10.38 p/Share	62,200 Reduced 1.95%	3,125,640 Common Stock
Apr 20 2022	SELL Open market or private sale	$889,498 $10.39 p/Share	85,611 Reduced 2.62%	3,187,840 Common Stock
Apr 19 2022	SELL Open market or private sale	$4,167,198 $10.42 p/Share	399,923 Reduced 10.89%	3,273,451 Common Stock

Also insider at

IMPL

IMPEL PHARMACEUTICALS INC Healthcare

vGS